Serum calcitriol concentrations measured with a new direct automated assay in a large population of adult healthy subjects and in various clinical situations

Clinica Chimica Acta

Volumn 451, Issue , 2015, Pages 149-153

  Souberbielle, Jean Claude ^a   Cavalier, Etienne ^b   Delanaye, Pierre ^b   Massart, Catherine ^c   Brailly Tabard, Sylvie ^d,e,f   Cormier, Catherine ^g   Borderie, Didier ^g   Benachi, Alexandra ^h   Chanson, Philippe ^d,e,f  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d BICÊTRE HOSPITAL   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f Bicêtre Paris Saclay Hospital   (France)

^g Institut Cochin   (France)

^h HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Calcitriol; Dialysis; Pregnancy; Primary hyperparathyroidism; Reference values; Vitamin D

Indexed keywords

CALCITRIOL;

ADOLESCENT; ADULT; AGED; AUTOMATION; BLOOD; BLOOD ANALYSIS; COHORT ANALYSIS; FEMALE; FRANCE; HUMAN; MALE; MIDDLE AGED; NORMAL HUMAN; PREGNANCY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOMATION; BLOOD CHEMICAL ANALYSIS; CALCITRIOL; COHORT STUDIES; FEMALE; FRANCE; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; PREGNANCY; YOUNG ADULT;

EID: 84952981889     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.09.021     Document Type: Article

References (35)

1. Holick M. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
2. Christakos S., Hewison M., Gardner D., Wagner C., Sergeev I., Rutten E., Pittas A., Boland R., Ferrucci L., Bikle D. Vitamin D: beyond bone. Ann. N. Y. Acad. Sci. 2013, 1287:45-58.
3. Holick M., Binkley N., Bischoff-Ferrari H., Gordon C., Hanley D., Heaney R., et al. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96:1911-1930.
4. Kallas M., Green F., Hewison M., White C., Kline G. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J. Clin. Endocrinol. Metab. 2010, 95:3111-3117.
5. Malloy P.J., Feldman D. Genetic disorders and defects in vitamin D action. Endocrinol. Metab. Clin. N. Am. 2010, 39:333-346.
6. Hollis B., Johnson D., Hulsey T., et al. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J. Bone Miner. Res. 2011, 26:2341-2357.
7. Patron P., Gardin J.P., Paillard M. Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int. 1987, 31:1174-1180.
8. Dusso A., Brown A.J., Slatopolsky E. Vitamin D. Am. J. Physiol. Ren. Physiol. 2005, 289:F8-F28.
9. Lund B., Sorensen O.H., Lund J., Bishop J., Norman A. Vitamin D metabolism in hypoparathyroidism. J. Clin. Endocrinol. Metab. 1980, 51:606-610.
10. 125I-labeled tracer. Clin. Chem. 1996, 45:586-592.
11. Frazer W., Durhan B., Berry J., Mawer E. Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Ann. Clin. Biochem. 1997, 34:632-637.
12. Casetta B., Jans I., Billen D., Bouillon R. Development of a method for the quantification of 1α,25(OH)2-vitamin D3 in serum by liquid chromatography-tandem mass spectrometry without derivatization. Eur. J. Mass Spectrom. 2010, 16:81-89.
13. Stratham F., Laha T., Hoofnagle A. Quantification of 1α,25-dihydroxy-vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Eur. J. Mass Spectrom. 2011, 57:1279-1285.
14. Van Helden J., Weiskirchen R. Experience with the first fully automated chemiluminescence immunoassay for the quantification of 1α,25-dihydroxy-vitamin D. Clin. Chem. Lab. Med. 2015, 53:761-770.
15. Koumakis E., Souberbielle J.C., Sarfati E., Meunier M., Maury E., Gallimard E., et al. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 2013, 98:3213-3220.
16. Delanaye P., Weekers L., Warling X., Moonen M., Smelten N., Medart L., Krzesinski J.M., Cavalier E. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrol. Dial. Transplant. 2013, 28:1779-1786.
17. Horn P., Feng L., Li Y., Pesce A. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin. Chem. 2001, 2137-3145.
18. Davies M., Adams P.H., Berry J.L., Lumb G.A., Klimiuk P.S., Mawer E.B., Wain D. Familial hypocalciuric hypercalcemia - observation on vitamin D metabolism and parathyroid function. Acta Endocrinol. (Copenh) 1983, 104:2010-2215.
19. Law W.M., Bollman S., Kumar R., Heath H. Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in hyperparathyroidism. J. Clin. Endocrinol. Metab. 1984, 58:744-747.
20. Christensen S.E., Nissen P., Vestergaard P., Heickendorff L., Rejnmark L., Brixen K., Mosekilde L. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur. J. Endocrinol. 2008, 159:719-727.
21. Moosgard B., Christensen S.E., Vestergaard P., Heickendorff L., Christiansen P., Mosekilde L. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin. Endocrinol. 2008, 68:707-715.
22. Lalor B., Mawer E.B., Davies M., Lumb G.A., Hunt L., Adams P.H. Determinants of the serum concentration of 1,25-dihydroxyvitamin D in primary hyperparathyroidism. Clin. Sci. 1989, 76:81-86.
23. -Thakker RV, Fraher LJ, Adami S, Karnali R, O'Riordan JL. Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism. Bone Miner. 1986; 1: 137-144.
24. Bergenfelz A., Lindegard B., Ahren B. Biochemical variables associated with bone density in patients with primary hyperparathyroidism. Eur. J. Surg. 1992, 158:473-476.
25. Nordenström E., Westerdahl J., Bergenfelz A. Recovery of bone mineral density in 126 patients after surgery for primary hyperparathyroidism. World J. Surg. 2004, 28:502-507.
26. Kumar R., Cohen W.R., Silva P., Epstein F.H. Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J. Clin. Invest. 1979, 63:342-344.
27. Reddy G.S., Norman A.W., Willis D.M., Goltzman D., Guyda H., Solomon S., Philips D.R., Bishop J.E., Mayer E. Regulation of vitamin D metabolism in normal human pregnancy. J. Clin. Endocrinol. Metab. 1983, 56:363-370.
28. Moller U.K., Streym S., Mosekilde L., Heickendorff L., Flyvbjerg A., Frystyk J., Jensen L.T., Rejnmark L. Changes in calciotropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study. Osteoporos. Int. 2013, 24:1307-1320.
29. Whitsett J., Ho M., Tsang R., Norman E., Adams K. Synthesis of 1,25-dihydroxyvitamin D3 by human placenta in vitro. J. Clin. Endocrinol. Metab. 1981, 53:484-488.
30. Halloran B.P., Schaefer P., Lifschitz M., Levens M., Goldsmith R.S. Plasma vitamin D metabolite concentrations in chronic renal failure: effects of oral administration of 25 hydroxyvitamin D3. J. Clin. Endocrinol. Metab. 1984, 59:1063-1069.
31. Jean G., Terrat J.C., Vanel T., et al. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6months of 25-hydroxycholecalciferol treatment. Nephron Clin. Pract. 2008, 110:c58-c65.
32. Jean G., Souberbielle J.C., Chazot C. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol. Dial. Transplant. 2009, 24:3799-3805.
33. Barbour G.L., Coburn J.W., Slatopolsky E., Norman A.W., Horst R.L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extra-renal generation of 1,25-dihydroxyvitamin D. N. Engl. J. Med. 1981, 305:440-443.
34. Lambert P.W., Stern P.H., Avioli R.C., Brachet N.C., Turner R.T., Greene A., Fu I., Bell N.H. Evidence for extra-renal production of 1-alpha-hydroxylase vitamin D in man. J. Clin. Invest. 1982, 69:722-725.
35. Dusso A., Lopez-Hilker S., Rapp N., Slatopolsky E. Extra-renal production of calcitriol in chronic renal failure. Kidney Int. 1988, 34:368-375.